Med3.0 healthcare
This blood test is specially designed for clients of Med3.0 Healthcare who want to assess their metabolic health, insulin resistance and risk of chronic disease. The study provides a comprehensive overview of important biomarkers involved in the regulation of blood sugar, lipid metabolism and inflammatory processes in the body.
Med3.0 Healthcare's vision is based on proactive healthcare: not waiting for disease to develop, but identifying risk factors early and improving them with targeted lifestyle interventions. Chronic diseases such as type 2 diabetes, cardiovascular disease and metabolic syndrome often develop for years before obvious symptoms appear. Timely measurement of biomarkers can reveal changes in the body at an early stage.
With this comprehensive blood test, you gain insight into various metabolic, cardiovascular and inflammation-related markers that together provide a clear picture of your current health status and any risk factors.
This blood test consists of:
- Glucose
- Insulin
- HbA1c
- Creatinine
- Hs-CRP
- ApoB
- Lp(a)
- Albumin (from urine)
- Creatinine (from urine)
The combination of these biomarkers allows early recognition of signs of insulin resistance, disturbances in lipid metabolism and chronic low-grade inflammation. Insulin resistance is seen by many experts as an important underlying factor in conditions such as type 2 diabetes, metabolic syndrome and cardiovascular disease.
Mapping these values gives you an objective starting point to improve your health with targeted lifestyle interventions in the areas of nutrition, exercise, sleep and stress management. This examination is often used as a starting point or monitoring within a program at Med3.0 Healthcare.
Do you need help interpreting your results? Our experts are here to guide you with appropriate advice.
